Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | AMGN | VRTX | REGN | GSK |
| Company | Editas Medicine | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.54 | 322.70 | 466.01 | 1,043.64 | 41.09 |
| High | 3.63 | 327.98 | 467.57 | 1,070.00 | 41.43 |
| Low | 3.42 | 320.52 | 461.49 | 1,036.88 | 40.66 |
| Last | 3.48 | 322.67 | 462.88 | 1,042.69 | 40.71 |
| Change | -0.01 | +3.57 | -0.27 | +2.73 | -0.19 |
| % Change | -0.29% | +1.12% | -0.06% | +0.26% | -0.46% |
| Volume | 2,060,700 | 2,432,500 | 710,700 | 659,600 | 3,137,115 |
| 20-Day Average Volume | 2,058,340 | 2,120,130 | 1,055,360 | 624,710 | 3,478,770 |
| Previous Close | 3.49 | 319.10 | 463.15 | 1,039.96 | 40.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.67 | 329.14 | 473.29 | 1,127.05 | 42.57 |
| 20-Day Raw Stochastic | 14.67% | 38.91% | 15.41% | 18.62% | 5.59% |
| 20-Day Relative Strength | 39.04% | 46.78% | 43.11% | 35.18% | 43.15% |
| Weighted Alpha | -69.39 | +19.45 | +27.77 | +22.55 | +8.92 |
| Today's Opinion | 100% Sell | 56% Buy | 24% Buy | 40% Buy | 24% Sell |
| Previous Opinion | 100% Sell | 40% Buy | 24% Buy | 40% Buy | 24% Sell |
| Last Month's Opinion | 100% Sell | 88% Buy | 80% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.69% since 09/20/24 | -4.36% since 09/20/24 | -0.44% since 09/20/24 | -8.94% since 09/20/24 | -0.22% since 09/20/24 |
| Low | 3.37 on 09/25/24 | 312.16 on 09/25/24 | 456.07 on 09/24/24 | 1,008.41 on 09/25/24 | 40.50 on 09/26/24 |
| High | 3.75 on 09/23/24 | 339.17 on 09/23/24 | 467.57 on 09/27/24 | 1,154.56 on 09/23/24 | 41.42 on 09/27/24 |
| 1-Month | |||||
| %Chg | -8.90% since 08/27/24 | -1.30% since 08/27/24 | -3.63% since 08/27/24 | -13.24% since 08/27/24 | -7.79% since 08/27/24 |
| Low | 3.37 on 09/25/24 | 312.16 on 09/25/24 | 456.07 on 09/24/24 | 1,008.41 on 09/25/24 | 40.50 on 09/26/24 |
| High | 4.12 on 09/18/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 1,210.97 on 08/29/24 | 44.26 on 09/04/24 |
| 3-Month | |||||
| %Chg | -26.58% since 06/27/24 | +2.86% since 06/27/24 | -2.04% since 06/27/24 | -0.78% since 06/27/24 | +5.36% since 06/27/24 |
| Low | 3.37 on 09/25/24 | 306.11 on 07/03/24 | 456.07 on 09/24/24 | 1,008.41 on 09/25/24 | 37.81 on 07/02/24 |
| High | 6.05 on 07/16/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 44.67 on 08/27/24 |
| 6-Month | |||||
| %Chg | -53.23% since 03/27/24 | +12.70% since 03/27/24 | +10.92% since 03/27/24 | +7.91% since 03/27/24 | -5.30% since 03/27/24 |
| Low | 3.37 on 09/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 37.81 on 07/02/24 |
| High | 7.52 on 03/28/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 287,011 | 171,176,416 | 119,517,248 | 114,589,024 | 84,764,512 |
| Shares Outstanding, K | 82,238 | 536,435 | 258,053 | 110,186 | 2,072,482 |
| Annual Sales | 78,120,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -153,220,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 510,000 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 9,950,400,000 |
| Last Quarter Net Income | -67,610,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,480,440,000 |
| 60-Month Beta | 1.99 | 0.61 | 0.40 | 0.12 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.82 on 08/07/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 1.09 on 07/31/24 |
| Latest Earnings Date | 11/01/24 | 10/30/24 | 11/04/24 | 11/07/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.378 on 08/16/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 08/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.82 | 0.00 | 26.84 | 9.75 |